Question 32

Carbamazepine has a narrow therapeutic index and requires serum concentrations to be monitored to prevent harm.

Carbamazepine is a medication with a narrow therapeutic index, meaning that the difference between the effective dose and the toxic dose is small. Therefore, monitoring serum concentrations is crucial to ensure patient safety and efficacy of treatment.

A) Carvedilol

Carvedilol is a beta-blocker primarily used for heart failure and hypertension treatment. It does not have a narrow therapeutic index and does not require routine serum concentration monitoring, making it less critical for avoiding toxicity compared to medications like carbamazepine.

B) Citalopram

Citalopram, an antidepressant belonging to the selective serotonin reuptake inhibitors (SSRIs) class, is generally considered safe without the need for serum concentration monitoring. It has a wider therapeutic index compared to carbamazepine, which minimizes the risk of harm from typical dosing.

C) Clindamycin

Clindamycin is an antibiotic used to treat various bacterial infections. It does not possess a narrow therapeutic index and does not require serum monitoring, as it can be administered safely without the risk of toxicity associated with narrow therapeutic index drugs like carbamazepine.

D) Carbamazepine

Carbamazepine is an anticonvulsant and mood-stabilizing medication that is known for its narrow therapeutic index. This characteristic necessitates regular monitoring of serum concentrations to avoid potential toxicity and ensure that the drug levels remain within the therapeutic range for effective treatment.

Conclusion

Carbamazepine is the only medication among the options presented that has a narrow therapeutic index, making it essential to monitor serum concentrations to prevent harm. In contrast, carvedilol, citalopram, and clindamycin do not require such monitoring due to their broader therapeutic ranges, highlighting the unique safety considerations associated with carbamazepine.